Mutational load of colorectal and non-colorectal cancers may benefit significantly from immunotherapy.Annual Meeting GI 2016

Mutational load of colorectal and non-colorectal cancers may benefit significantly from immunotherapy.Annual Meeting GI 2016

473 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
David H. Ilson, MD of Memorial Sloan Kettering Cancer Center discusses mutational load of colorectal and non-colorectal cancers may benefit significantly from immunotherapy.at ASCO GI 2016
Up Next Autoplay
>